SCHEMBL28101728

SCHEMBL28101728

CC(C)[C@H](N)COC(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.44
CHRNB2 P17787 2/20 0.41
CHRNA4 P43681 2/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CYP1A2 P05177 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP2D6 P10635 2/20 0.39
PKM P14618 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
LMNA P02545 6/20 0.37
TSHR P16473 6/20 0.37
CHRM2 P08172 3/20 0.37
CHRM4 P08173 3/20 0.37
CHRM5 P08912 3/20 0.37
CHRM1 P11229 3/20 0.37
CHRM3 P20309 3/20 0.37
HTR1A P08908 1/20 0.37
CYP2C19 P33261 1/20 0.37
CHRNA7 P36544 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28101763 1.00 ALOX15 (0.44) ALOX15CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL12414724 0.81 SCN4A (0.34) ALOX15CYP1A2SMN1; SMN2CYP2D6TSHR
SCHEMBL13003643 0.81 TDP1 (0.42) ALOX15CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL12414718 0.81 SCN4A (0.34) ALOX15CYP1A2SMN1; SMN2CYP2D6TSHR
SCHEMBL189149 0.80
SCHEMBL16103647 0.80
SCHEMBL13030933 0.79 SLC7A5 (0.42) CYP1A2CYP2D6TSHRSCN4ACYP3A4
SCHEMBL13030932 0.79 SLC7A5 (0.42) CYP1A2CYP2D6TSHRSCN4ACYP3A4
SCHEMBL4200761 0.79 SMN1; SMN2 (0.38) CYP1A2SMN1; SMN2CYP2D6TSHRSCN4A
SCHEMBL224726 0.78 ALOX15 (0.46) ALOX15CHRNB2CHRNA4CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108434149-A For the regulated treatments of HSPC of Rb positive abnormal cell proliferations G1治疗公司 2018-08-24 CN disclosed
CN-108283644-A To the instantaneous protection of normal cell during chemotherapy G1治疗公司 2018-07-17 CN disclosed
CN-105407889-B HSPC-sparing therapy for Rb-positive abnormal cell proliferation G1治疗公司 2018-06-01 CN disclosed
CN-105473140-B Transient protection of normal cells during chemotherapy G1治疗公司 2018-04-10 CN disclosed
CN-106008533-B CDK inhibitor G1治疗公司 2018-01-23 CN disclosed
CN-107417691-A Efficient anti-superfluous raw agent and anti-proliferative agent G1治疗公司 2017-12-01 CN disclosed
CN-106967074-A CDK inhibitor G1治疗公司 2017-07-21 CN disclosed
CN-103936745-B Cdk inhibitors G1治疗公司 2017-04-12 CN disclosed
CN-106008533-A Cdk inhibitors G1治疗公司 2016-10-12 CN disclosed